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Background:Themechanism bywhich BALB/cmice exhibit a propensity to induce T helper 2 (Th2) responses and allergic
diseases is unknown.
Results: Prostaglandin endoperoxide E2 (PGE2) prevents activation-induced cell death in Th2 cells of BALB/c mice via the
E-prostanoid 2 (EP2) receptor and is dependent on granzyme B.
Conclusion: Signaling of PGE2 through EP2 promotes Th2 immune responses.
Significance: EP2 can be targeted as a therapeutic modality for Th2-mediated diseases.
T helper 2 (Th2) cells play a central role in the progression of
many diseases such as allergic airway inflammation, autoim-
mune diseases, and infections caused by intracellular patho-
gens. Consequently, animals such as BALB/c mice, which
exhibit a propensity for generating Th2 responses, are suscepti-
ble to allergic airway inflammation, type-II autoimmune dis-
eases, and various infections induced by intracellular patho-
gens, namely, Leishmania. In contrast, C3H/OuJ mice have a
tendency for generating T helper 1 (Th1) responses and show
resistance to these diseases. Here, we show that prostaglandin
endoperoxide E2 selectively inhibits activation-induced cell
death of Th2 cells by signaling through its receptor E-prostan-
oid receptor 2 (EP2). Consequently, Th2 cells derived from
BALB/c mice expressed very high levels of EP2. On the other
hand, Th2 cells derived from C3H/OuJ mice expressed very low
levels of EP2, which failed to support the survival of Th2 cells.
Furthermore, we found that this effect of EP2 on Th2 cells from
BALB/c mice was executed by a granzyme B-mediated mecha-
nism. EP2 belongs to a group of G-protein-coupled receptors
that are amenable to therapeutic targeting. Our findings there-
fore identify EP2 as a promising target for small molecule-di-
rected immunomodulation.
Animalmodels ofmany human diseases have become funda-
mental experimental tools in biology. Inbred strains of mice
have been extensively used for studying the immunological
basis of susceptibility or resistance to various human diseases
that a particular genetic constitution confers upon the host.
Certain mouse strains such as BALB/c (haplotype H2d), which
have a propensity for inducing T helper 2 (Th2)3-biased
immune responses, are highly susceptible to allergic airway
inflammation, humoral autoimmune inflammation, and infec-
tion by intracellular pathogens (1, 2). On the other hand,mouse
strains such as C3H (haplotype H2k), which predominantly
mount Th1-biased responses, are resistant to allergic airway
inflammation (3) and successfully clear intracellular pathogens
(1). Therefore, these strains are often employed as models to
study various diseases. However, the mechanism that underlies
the immunological divergence of these strains is not well
understood. Identification of genetic differences that are
responsible for the immunological differences in these two
types of mouse strains might lead to the identification of novel
targets for therapeutic intervention in allergic, autoimmune,
and infectious diseases.
Polarization of Th cell responses is governed by two funda-
mental processes: (i) differentiation and (ii) maintenance of
polarized effector cells. Considerable efforts have beenmade to
correlate the differentiation process, and these studies have
identified various factors involved in the differentiation of dis-
tinct Th cell subsets (4–7). However, the effector state of an
immune response is determined by a dynamic balance between
the generation of these effector cells and effector cell survival
and death. Activated cells are eliminated from the system by an
active process called activation-induced cell death (AICD). The
role of AICD in the polarization of effector Th cell responses
has not been well studied. In the last three decades, several Th
cell subsets have been described in various circumstances, and
the list is still growing. However, the biology of IFN--produc-
ing Th1 cells and IL-4-producing Th2 cells has been well stud-
ied in multiple diseases (8–11). In a given polarized condition,
Th1 and Th2 cells are in a dynamic balance (8–11), which in
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nological and infectious diseases such as allergic asthma (12)
and leishmaniasis (13–15).
Here, we studied AICD of Th cells and the consequences of
Th cell polarization in BALB/c and C3H/OuJ mice. We found
that the C3H/OuJ strain does not support survival of Th2 cells
in vivo. Prostaglandin endoperoxide E2 (PGE2) derived from
macrophages inhibitedAICDofTh2 cells derived fromBALB/c
mice but not those derived from C3H/OuJ mice. Finally, we
showed that expression of the E-prostanoid receptor 2 (EP2) on
Th2 cells is dramatically reduced in C3H/OuJ mice as com-
pared with BALB/c mice.
EXPERIMENTAL PROCEDURES
Mice and Reagents—Female BALB/c mice were initially
obtained fromThe Jackson Laboratory, Bar Harbor,ME. These
mice were maintained in a specific pathogen-free animal facil-
ity at the International Center forGenetic Engineering and Bio-
technology (ICGEB), New Delhi, India. Female mice at 6–8
weeks of age were used throughout the study following institu-
tional ethical committee guidelines. Purified anti-IL4 (11.B.11),
anti-IFN- (XMG1.2), and anti-IL12 (C17.8) antibodies,
recombinant mouse IL-12p70, and purified mouse IL-4 were
obtained from eBioscience, Inc. Fluorescently labeled anti-
CD4, anti-TCR-, and anti-granzyme B (GrB) antibodies and
isotype controls and purified anti-CD3 (145.2C.11) and anti-
CD28 (37.51) antibodies were purchased from BD Biosci-
ences. Purified mouse IL-2 (R&D systems), ovalbumin
(OVA), PGE2, and indomethacin were purchased from
Sigma. Accell siRNA delivery reagents and EP2 small inter-
fering RNA (siRNA) were purchased from Dharmacon. EP2
receptor antagonist AH6809 was purchased from Cayman
Chemical. EP2 receptor and donkey anti-rabbit immuno-
globulin G-conjugated horseradish peroxidase antibodies
were purchased from Abcam Biochemicals.
Differentiation of T Helper Cell Subsets and Cytokine
Detection—CD4 T cells were purified from splenocytes by
positive selection using a mouse CD4 T cell isolation kit
(Miltenyi Biotech). Differentiation of Th1 and Th2 cells was
performed as described elsewhere (16). Briefly, CD4T cells at
1  106 cells/ml were activated with plate-bound anti-CD3 (1
g/ml) and anti-CD28 (2 g/ml) antibodies for 96 h. Cultures
were supplemented with IL-2 (100 units/ml), IL-12 (10 ng/ml),
and anti-IL-4 antibodies (10g/ml) for Th1 cell differentiation,
whereas IL-4 (10 ng/ml), anti-IL-12 (10g/ml), and anti-IFN-
(10 g/ml) antibodies were used for Th2 cell differentiation.
Cells were rested under the above cytokine conditions in the
absence of anti-CD3 and anti-CD28 antibodies for an addi-
tional 48 h. These cells (1  106/ml) were then restimulated
with plate-bound anti-CD3 and anti-CD28 antibodies, and
supernatant was collected after 48 h for phenotype detection
using X-map Luminex cytokine detection technology. AICD
experiments of Th1 and Th2 cells were performed by stimulat-
ing cells (1  106 cells/well/ml) with plate-bound anti-CD3
antibodies (1g/ml) for 16 h. Cell deathwasmeasured by stain-
ing with propidium iodide (PI) (16). Briefly, cells were washed
in phosphate-buffered saline (PBS) and resuspended in DNA
staining buffer consisting of 0.5% saponin, 50 g/ml PI, and 0.1
mg/ml RNase A in PBS and analyzed by flow cytometry for the
percentage of cells in the hypodiploid region. Supernatants
from lipopolysaccharide (LPS)-activated macrophages were
generated by activating RAW 264.7 cells with LPS (100 ng/ml)
for 24 h. Some of the cultures were supplemented with indo-
methacin (10 M) to inhibit prostaglandin production. These
supernatants were used at a ratio of 1:1 to assess their effects on
AICD of differentiated Th1 andTh2 cells. PGE2 (100 nM–1M)
was used to assess its effect on AICD in terminally differenti-
ated Th1 and Th2 cells of BALB/c and C3H/OuJ mice. All cell
culturesweremaintained inRPMI 1640mediumsupplemented
with 2mM L-glutamine, 50M 2-mercaptoethanol, heat-inacti-
vated FBS (10%), and 10 mM gentamycin. The protein level of
GrB was measured in Th2 cells in the presence or absence of
PGE2 after activation with plate-bound anti-CD3. These exper-
iments are representative of three independent experiments.
FACS Staining and Analysis—Th2-differentiated cells from
BALB/c and C3H/OuJ mice were surface-stained with anti-
CD4 antibody (eBioscience), and then GrB was detected by
intracellular staining using phycoerythrin-labeled anti-GrB
antibody (clone:16G6, eBioscience).
RNA Interference—Cells were transfected with siRNA for
EP2 using the Accell delivery medium (Dharmacon) according
to the manufacturer’s protocol. EP2-specific and nontargeting
siRNA were used at 1 M concentration and incubated with
cells for 96 h before cells were used for further processing.
Antigen-specific T Cell Proliferation Assay—For determina-
tion of antigen-specific T cells, 6–8-week-old female BALB/c
andC3H/OuJmice were immunized intraperitoneally with 100
g of OVA plus alum (Pierce) in 0.2 ml of PBS on days 0 and 7
and sacrificed onday 9 to harvest the spleen anddraining lymph
nodes. OVA-specific T cells were expanded in culture in the
presence of OVA (50 g/ml) for 72 h followed by resting for
48 h. Cells were then restimulated with various OVA concen-
trations for 72 h. OneCi/well [3H]thymidine was added to the
cultures for the last 12 h. Cells were harvested using the Filter-
Mate cell harvester, and radioactivity counts were obtained
using MicroBeta TriLux (PerkinElmer Life Sciences). Culture
supernatants were collected at 48 h of in vitro stimulation with
OVA, and cytokines were quantified using the Luminex xMAP
technology.
T Cell Adoptive Transfer—OVA-specific Th cells from
BALB/c and C3H/OuJ mice were expanded in vitro by restim-
ulating draining lymph node cells derived from OVA-immu-
nized animals. Cells were labeled with 5M carboxyfluorescein
diacetate-succinimidyl ester (CFDA-SE) per 5 106 cells, and
10  106 cells were adoptively transferred into syngeneic
BALB/c or C3H/OuJ mice, respectively, via tail vein in a total
volume of 100 l PBS. These mice were immunized with OVA
and alummixture 24 h prior to adoptive transfer and also at the
time of transfer. Five days later, cells were harvested from
spleens and assessed for the presence ofCFDA-SE-labeled cells.
Quantitative Real-time PCR—Total RNA was isolated with
an RNeasymini kit (Qiagen). Genomic DNAwas removed with
RNase-freeDNase prior to cDNA synthesis. First-strand cDNA
synthesis was performed for each RNA sample with the Sensis-
cript RTkit (Qiagen). Reverse-transcribed cDNAwas subjected
to real-time PCR with the SYBR Green master mix (Qiagen).
EP1, EP2, EP3, EP4, and -actin real-time PCR primer
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sequences were: EP1 forward, 5-CTCCTTGCGGCATTAGT-
GTG-3, reverse, 5-TGCGGTCTTTCGGAATCGT-3; EP2
forward, 5-CGTTATCCTCAACCTCATTCGC-3, reverse,
5-TCCGTCTCCTCTGCCATCG-3; EP3 forward, 5-TTGC-
TGGCTCTGGTGGTGAC-3, reverse, 5-GCTGGACTGCG-
AGACGGC-3; EP4 forward 5-TGACCCAAGCAGACACC-
ACCT-3, reverse, 5-TCCCACTAACCTCATCCACCAA-3.
The relative expression level of mRNAs was normalized to that
of internal control -actin by using the 2Ct cycle threshold
method.
Western Blot Analysis—Whole cell extract was prepared
after restimulation of Th1- or Th2-differentiated cells from
BALB/c and C3H/OuJ mice with Triton X-100 buffer (50
mmol/liter Tris (pH 7.5), 150 mmol/liter NaCl, 0.5% Triton
X-100). Samples were electrophoresed on a 12% SDS-poly-
acrylamide gel and electroblotted onto polyvinylidene difluo-
ride (PVDF) membranes. Blots were blocked for 1 h in 5% BSA
in PBS. EP2 (40-kDa) protein was detected with anti-EP2 poly-
clonal antibody as recommended by themanufacturer (Abcam)
and diluted at 1:500; in addition, donkey anti-rabbit-immuno-
globulin G-conjugated horseradish peroxidase (diluted 1:5000)
was used as a secondary antibody. Immunoblotting for -actin
was carried out to confirm equal loading.
Statistical Analysis—Differences in treatment groups were
assessed by paired two-tailed Student’s t test using Prism soft-
ware (GraphPad).
RESULTS ANDDISCUSSION
C3H/OuJ Mice Fail to Support Th2 Cell Survival in Vivo—It
is well established that BALB/c mice tend to mount Th2
responses, whereas C3H/OuJ mice have a propensity to induce
Th1 responses (17). However, the mechanisms involved in this
differential response are not clear. Therefore, we revisited this
issue. First, we determined whether C3H/OuJ mice have an
inherent deficiency in the differentiation of naive CD4 T cells
toward the Th2 cell lineage. Purified CD4 T cells from C3H/
OuJ and BALB/c mice were subjected to Th1 and Th2 cell dif-
ferentiation and analyzed for cytokine production. We did not
observe any noticeable differences in the differentiation of Th1
or Th2 cells between the two strains (Fig. 1a). Second, to deter-
mine whether differential responses are due to poor mainte-
nance of the Th1 or Th2 cell subset, we tested whether there is
FIGURE1.BALB/cmice support survival of Th2 cells in vivo,whereasC3H/OuJmicedonot.a, BALB/c andC3H/OuJmicegenerate comparable Th1 andTh2
cell responses in vitro. CD4 T cells fromBALB/c andC3H/OuJ strainswere stimulatedwith plate-bound anti-CD3 (1g/ml) and anti-CD28 (2g/ml) antibodies
under Th1- or Th2-primingconditions. Terminally differentiated cellswere restimulatedwithplate-boundanti-CD3andanti-CD28antibodies, and supernatant
was collected after 48 h for cytokine measurements. b, C3H/OuJ mice generate attenuated antigen-specific T cell responses to OVA immunization. Draining
lymph node cells were harvested from mice immunized with OVA  alum and in vitro challenged with OVA at various concentrations. Proliferation was
assessed following culture for 72 h in vitro and pulsing with [3H]thymidine for the last 8–10 h of incubation time. c, cytokine production was determined from
the culture supernatants of the cells stimulated with 70 g/ml OVA from the above culture plates after 48 h of incubation. d, OVA antigen-specific Th cells of
both BALB/c andC3H/OuJmicewere expanded in vitro, CFDA-SE-labeled, and adoptively transferred in syngeneic BALB/c andC3H/OuJmice (immunizedwith
OVA alum), respectively. After 5 days, spleens and lymph node cells were harvested and assessed for the presence and proliferation of the transferred cells
usingFACS. SSC-H, side scatter pulseheight;CFSE, carboxyfluorescein succinimidyl ester. Representativedata (meanS.E.) in triplicatewells fromat least three
independent experiments are shown. ***, p 0.001 versus untreated.
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any difference in Th2-biased immune responses between C3H/
OuJ and BALB/c mice. We immunized mice with OVA anti-
gens emulsified in alum and measured antigen-specific prolif-
eration and cytokine responses. We found that as compared
with BALB/c mice, C3H/OuJ mice generated significantly
lower proliferative and Th2 cytokine responses to OVA anti-
gens (Fig. 1, b and c). Using this immunization protocol, we
were unable to detect IFN- production by T cells from either
of these strains (data not shown). Finally, we tested the possi-
bility that C3H/OuJ mice have a defect in the maintenance of
Th2 cells. For this purpose, we expandedOVA antigen-specific
Th2 cells of both BALB/c and C3H/OuJ mice in vitro. These
cells were labeled with the dye CFDA-SE and were adoptively
transferred into syngeneic C3H/OuJ and BALB/c mice, respec-
tively. These mice were then immunized with OVA and alum
mixture. Five days later, cells were harvested from spleens and
lymph nodes and assessed for the presence and cellular division
of adoptively transferred Th2 cells. We recovered fewer Th2
cells from C3H/OuJ mice, and these cells had divided fewer
times than theTh2 cells fromBALB/cmice (Fig. 1d). Therefore,
C3H/OuJ mice fail to support the maintenance of Th2 cells.
Prostaglandin E2 Mediates the Differential Susceptibility of
Th2 Cells from BALB/c and C3H/OuJMice to AICD—Polariza-
tion and maintenance of an effective immune response is a
dynamic process (18). Some of the effector cells are continu-
ously eliminated by an active process called AICD (18). There-
fore, we tested AICD in Th1 and Th2 cells from BALB/c and
C3H/He mice in vitro. Terminally differentiated Th1 and Th2
cells were activated overnight with plate-bound anti-CD3 anti-
bodies. We found that AICD was induced in Th1 and Th2 cells
FIGURE 2. PGE2 inhibits AICD of Th2 cells derived from BALB/c but not C3H/OuJ mice. a, terminally differentiated Th1 and Th2 cells were activated with
plate-bound anti-CD3 antibodies overnight. DNA fragmentationwasmeasured by PI staining. Th1 and Th2 cells of these strains induced comparable AICD (left
two setsof panels). Supernatant (Sup) fromLPS-activatedmacrophages drastically inhibitedAICD in Th2 cells of BALB/c but not C3H/OuJ origin (middle panels).
Supernatant from LPS-activatedmacrophages generated in the presence of indomethacin (IM; 10M) did not alter the inhibition of AICD in Th2 cells of either
strain (second setofpanels fromthe right). Theadditionof PGE2 to the culturemedium (1M)dramatically inhibitedAICDof Th2cells of BALB/cbutnotC3H/OuJ
origin (right panels). Numbers indicated in the figures are the percentages of apoptotic cells. b, expression of PGE2 receptor EP2 in Th2 cells from BALB/c and
C3H/OuJ mice. Th1 and Th2 cells from BALB/c and C3H/OuJ mice were activated with plate-bound anti-CD3  anti-CD28 antibodies, and total mRNA was
isolated. Quantitative real-time PCR was performed for quantifying expression of PGE2 receptors. Relative expression was calculated using -actin as an
internal control. c, Western blot analysis of EP2 receptor (40 kDa) levels in Th1 and Th2 cells of BALB/c andC3H/OuJmice. Terminally differentiated Th1 and Th2
cells were activated with plate-bound anti-CD3 anti-CD28 antibodies. -Actin (47 kDa) was used as an internal control. d, expression of GrB was measured
in Th2 cells in the presence or absence of PGE2 after activationwith plate-bound anti-CD3 antibodies. The red line indicates GrB staining, whereas the blue area
indicates isotype control. e, selective inhibitionof EP2by siRNAabrogates theAICD inhibitory activity of PGE2. Terminally differentiatedTh2cellswere activated
on plate-bound anti-CD3 overnight. Supernatant from LPS-activatedmacrophages inhibited AICD in control andmock-treated Th2 cells but not in EP2-siRNA
(1M)-treated cells. DNA fragmentationwasmeasured by PI staining. f, PGE2 is unable to inhibit AICD of Th2 cells derived from BALB/cmice in the presence of
EP2 receptor antagonist AH6809 (100M).Numbers indicated in the figures are the percentage of apoptotic cells. Data presented here are representative of at
least three independent experiments.
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from each of these strains at comparable levels (Fig. 2a, left
panels). Therefore, we concluded that intrinsic susceptibility to
effector T cell death is not responsible for the observed differ-
ences in immune responses between the two mouse strains.
Because AICD is controlled in vivo by active mechanisms (19),
we tested the role of antigen-presenting cells in the differential
death of differentiated Th cells from BALB/c and C3H/OuJ
mice. We first prepared supernatants from LPS-activated
macrophages by treating RAW 264.7 cells with 100 ng/ml LPS
for 24 h.We found that supernatant fromLPS-activatedmacro-
phages profoundly inhibited AICD in Th2 cells from BALB/c
but not C3H/OuJ mice (Fig. 2a, middle panels). Therefore, we
concluded that the LPS-activated supernatant contains AICD
inhibitory factors.
Previously, it has been shown that apoptosis in B cells, imma-
ture thymocytes, and tumor cell lines is controlled by PGE2
(20). In fact, PGE2 promotes the survival of cancer cells (21).
Therefore, we tested whether prostaglandins are responsible
for the inhibitory effect of supernatant from LPS-activated
macrophages on AICD in Th2 cells from BALB/c mice. We
prepared supernatants from LPS-activated macrophages in the
presence of indomethacin, an inhibitor of prostaglandin syn-
thase. Although indomethacin did not affect cytokine produc-
tion (supplemental Fig. 1), these supernatants were unable to
inhibit AICD inTh2 cells fromBALB/cmice (Fig. 2a, second set
of panels from the right). These findings suggested that prosta-
glandins play a role in protecting Th2 cells from AICD in
BALB/c but not C3H/OuJ mice. It is well known that PGE2
contributes to the polarization of Th2 cell responses and has
been implicated in the generation of allergic immune responses
(22). Consistent with our studies using supernatants from LPS-
activated macrophages, the addition of commercially available
PGE2 to the culture medium dramatically inhibited AICD in
Th2 cells from BALB/c but not C3H/OuJ mice (Fig. 2a, right
panels). These findings suggested that Th2 cells fromC3H/OuJ
mice are defective in PGE2-mediated inhibition of AICD.
PGE2 Receptor EP2 Is Differentially Regulated in Th2 Cells of
BALB/c and C3H/OuJ Mice—We examined the expression of
PGE2 signaling components in Th1 and Th2 cells of BALB/c
and C3H/OuJ mice. First, we analyzed the expression of PGE2
receptors. There are four receptors (EP1–EP4) for PGE2 with
wide expression profiles in tissues and cells (23). To determine
the expression of these receptors, we generated Th1 and Th2
cells from purified CD4 T cells of either of the stains and
activated the cells with plate-bound anti-CD3 and anti-CD28
antibodies. Total RNA was extracted and subjected to quanti-
tative PCR for EP1, EP2, EP3, and EP4 using specific primer
probes (Fig. 2b). We were unable to detect expression of EP1 in
Th1 or Th2 cells of either mouse strain. In contrast, EP2 was
expressed significantly higher in Th2 cells of BALB/c origin
than those of C3H/OuJ origin. Th1 cells of either of these
strains lacked EP2 expression. EP3was expressed inTh1 cells of
both strains, but was not expressed in Th2 cells of either strain.
In contrast, expression of EP4 was detected in both Th1 and
Th2 cells of both strains. Based on these findings, we predicted
that EP2-mediated signalingmay play a role in the inhibition of
AICD in Th2 cells of BALB/c mice and that the absence of EP2
mediates the resistance of Th2 cells from C3H/OuJ mice to
AICD.
To further confirm that BALB/cmice andC3Hmice differ in
EP2 expression, we performed Western blot analysis of EP2 in
terminally differentiated and reactivated Th1 and Th2 cells
derived from BALB/c and C3H/OuJ mice. Interestingly, we
observed that Th2 cells derived fromBALB/c but not C3H/OuJ
mice expressed EP2 receptor (Fig. 2c). As expected, Th1 cells
from neither of these strains expressed EP2 (Fig. 2c).
PGE2MediatesAICD inTh2Cells fromBALB/cMice viaGrB—
Previously, we have shown that AICD of Th2 cells is mediated
by cytosolic GrB (16). Therefore, we tested GrB expression in
Th2 cells treated with PGE2. We found that PGE2 dramatically
inhibits GrB expression in Th2 cells of BALB/c but not C3H/
OuJ origin (Fig. 2d). These findings suggested that activation
ofEP2 in Th2 cells by PGE2 prevents AICD by inhibiting GrB
production.
To further confirm that EP2 plays a role in the observed inhi-
bition of AICD mediated by PGE2 in BALB/c mice, we per-
formed knockdown experiments of EP2 by siRNA in Th2 cells
of BALB/c mice. Transfection efficiency was assessed by using
green nontargeting siRNA (supplemental Fig. 2). As expected,
EP2 knockdown Th2 cells remained susceptible to AICD even
in the presence of PGE2 (Fig. 2e). To provide further evidence
for the role of EP2 for inhibiting AICD of Th2 cells, we per-
formed receptor competition assays. We pretreated Th2 cells
with EP2 receptor antagonist AH6809 and then performed
AICD assays in the presence or absence of PGE2. As shown in
Fig. 2f, the presence of the EP2 antagonist dramatically abro-
gated PGE2-mediated inhibition of AICD. Taken together,
these data provide strong evidence that in the absence of EP2
receptor activity, PGE2 is unable to exhibit its inhibitory effect
on AICD.
PGE2 is widely known for its immunoregulatory functions,
promotion of tumor growth, and inhibition of thymocyte apo-
ptosis (24). It is also known that PGE2 plays critical roles in the
development of Th2 cell responses (25). However, a role of
PGE2 in susceptibility of BALB/c mice to various diseases has
not been fully established. Until now, the relevant receptor that
is responsible for the Th2 cell-enhancing activities of PGE2 has
remained unknown. Our study provides strong evidence that
signaling of PGE2 through EP2 promotes Th2 immune
responses. Therefore, EP2 is an attractive target formodulating
Th2 cell-mediated inflammatory and infectious diseases. EP2
is a G-protein-coupled receptor, and thus, pharmacological
antagonists can be designed to inhibit its functions (26, 27). All
commercially available EP2 antagonists cross-react with EP4,
which has an opposing function to EP2. Specific antagonists to
EP2 will need to be designed to selectively inhibit the Th2-
promoting activities of PGE2 during therapy.
In summary, we have shown that EP2 plays a role in the
polarization of Th2 cells by inhibiting AICD in these cells.
Thus, EP2 is an attractive new target for therapeutic interven-
tion in allergic and infectious diseases.
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